BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33925132)

  • 1. The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.
    Ge Y; Huang M; Yao YM
    Cells; 2021 Apr; 10(5):. PubMed ID: 33925132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high mobility group box-1 protein on immune cells and its regulatory mechanism.
    Luan YY; Yao FH; Zhang QH; Zhu XM; Dong N; Yao YM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Nov; 28(6):548-54. PubMed ID: 23581184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility group box-1 in sterile inflammation.
    Tsung A; Tohme S; Billiar TR
    J Intern Med; 2014 Nov; 276(5):425-43. PubMed ID: 24935761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.
    Lu B; Wang C; Wang M; Li W; Chen F; Tracey KJ; Wang H
    Expert Rev Clin Immunol; 2014 Jun; 10(6):713-27. PubMed ID: 24746113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.
    Paudel YN; Angelopoulou E; Piperi C; Balasubramaniam VRMT; Othman I; Shaikh MF
    Eur J Pharmacol; 2019 Sep; 858():172487. PubMed ID: 31229535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of high mobility group box 1 in innate immunity.
    Lee SA; Kwak MS; Kim S; Shin JS
    Yonsei Med J; 2014 Sep; 55(5):1165-76. PubMed ID: 25048472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target.
    VanPatten S; Al-Abed Y
    J Med Chem; 2018 Jun; 61(12):5093-5107. PubMed ID: 29268019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity.
    Li L; Lu YQ
    Front Immunol; 2020; 11():601815. PubMed ID: 33552058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
    Lutz W; Stetkiewicz J
    Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation.
    Kim SY; Son M; Lee SE; Park IH; Kwak MS; Han M; Lee HS; Kim ES; Kim JY; Lee JE; Choi JE; Diamond B; Shin JS
    Front Immunol; 2018; 9():705. PubMed ID: 29696019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
    Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
    Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1, a novel inflammatory cytokine.
    Yamada S; Maruyama I
    Clin Chim Acta; 2007 Jan; 375(1-2):36-42. PubMed ID: 16979611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity.
    Ciucci A; Gabriele I; Percario ZA; Affabris E; Colizzi V; Mancino G
    PLoS One; 2011; 6(8):e23766. PubMed ID: 21915243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Mobility Group Box-1 and Blood-Brain Barrier Disruption.
    Nishibori M; Wang D; Ousaka D; Wake H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lower concentration thrombin on high-mobility group box 1 protein-mediated inflammatory responses.
    Bae JS
    Inflammation; 2012 Jun; 35(3):1078-86. PubMed ID: 22139321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
    Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
    Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1 protein does not mediate the inflammatory response in spontaneous spinal cord regeneration: a hint for CNS regeneration.
    Dong Y; Gu Y; Huan Y; Wang Y; Liu Y; Liu M; Ding F; Gu X; Wang Y
    J Biol Chem; 2013 Jun; 288(25):18204-18. PubMed ID: 23649623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair.
    Bianchi ME; Crippa MP; Manfredi AA; Mezzapelle R; Rovere Querini P; Venereau E
    Immunol Rev; 2017 Nov; 280(1):74-82. PubMed ID: 29027228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release.
    Yang H; Hreggvidsdottir HS; Palmblad K; Wang H; Ochani M; Li J; Lu B; Chavan S; Rosas-Ballina M; Al-Abed Y; Akira S; Bierhaus A; Erlandsson-Harris H; Andersson U; Tracey KJ
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11942-7. PubMed ID: 20547845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.